No insider purchase over the last 90 days. The latest, by Richard Sederman, was filed 28 Apr 2026.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
FY ended December 2025 · cache
25 of 76 declarations
At Essentra plc, the three largest purchases are all by Paul Forman (Chief Executive) in 2017: EUR 125,678 on April 20, EUR 114,970 on August 10 and EUR 90,736 on August 1. The record counts 30 purchases, 19 of them with an amount worth EUR 506,495, but the median is only EUR 3,277, and purchases are 77% of open-market trades. Paul Forman signs 6 filings, 4 of them purchases; Lorraine Trainer (Non-Executive Director) 6, all purchases, and Rowan Baker (Chief Financial Officer) 4, also purchases.
The sales, 9 of which 4 carry an amount worth EUR 178,343 (median EUR 37,648), come mostly from Richard Cammish (Chief Information Officer): EUR 86,598 on March 3, 2021, then EUR 37,663 on March 31 and EUR 37,634 on April 1, 2021. Scott Fawcett (Chief Executive Officer) is the most frequent filer, with 13 filings including 1 purchase and 3 sales.
From March 17 to April 15, 2026, 5 insiders bought. Of 76 filings from 30 insiders between December 16, 2016 and April 28, 2026, 30 are grants and 7 are option exercises. Annual volume climbs to 21 in 2021, after 2 in 2020. Insiders hold 9.5% of this UK company, classed as Chemicals & Materials. Over the last twelve months: 11 filings, 7 purchases, 3 sales.
For the 30 purchases with a 90-day result, the median is 1% and 53% are positive (recorded past results, not a forecast).